表紙:視神経障害治療の世界市場規模調査&予測:治療タイプ別、適応症別、エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1261201

視神経障害治療の世界市場規模調査&予測:治療タイプ別、適応症別、エンドユーザー別、地域別分析、2022-2029年

Global Optic Nerve Disorders Treatment Market Size study & Forecast, by Treatment Type, by Indication, by End-User and Regional Analysis, 2022-2029

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.43円
視神経障害治療の世界市場規模調査&予測:治療タイプ別、適応症別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年04月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

視神経障害は、一般的に発達障害や後天的な障害によって引き起こされる視力低下のパターンと定義されます。

また、視神経やその脳への伝達経路に障害が生じると、視力が低下します。視神経に影響を与える疾患には、視神経コロボーマ、緑内障、特発性頭蓋内圧亢進症、視神経脊髄炎、視神経萎縮、視神経ドルーゼン、視神経孔、視神経炎、視神経分離症、毒性弱視(栄養性弱視)など、さまざまな種類があります。緑内障の発症率の上昇と高齢化人口の増加は、市場成長を促進する主な要因です。

老年人口の増加は、視神経障害治療の世界市場の成長に寄与しています。世界銀行グループによると、世界の老齢人口は2020年に7億2,700万人であり、今後30年間で3倍になり、2050年には15億人に達すると予測されています。また、宇宙を牽引するもう一つの重要な要素は、緑内障の増加です。例えば、世界緑内障協会-2020年、世界では約7,960万人が緑内障に罹患しており、予測によると、この数は2040年には1億1,180万人に増加すると考えられています。また、製薬・バイオテクノロジー産業の拡大やヘルスケア支出の増加は、予測期間中、同市場に有利な成長見通しをもたらすと考えられます。しかし、視神経障害治療の高コストが、2022年から2029年の予測期間を通じて市場成長を阻害します。

視神経障害治療の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、これらの地域の各国政府によるヘルスケア支出の増加や視神経障害に関する認知度の向上などの要因により、売上高で市場を独占しています。一方、アジア太平洋地域は、老年人口やターゲット人口の増加、同地域における主要な市場プレイヤーの存在などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年~2029年
    • 視神経障害治療市場、地域別、2019-2029年
    • 視神経障害治療市場、治療タイプ別、2019-2029年
    • 視神経障害治療薬市場、適応症別、2019-2029年
    • 視神経障害治療薬市場、エンドユーザー別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 世界の視神経障害治療市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 視神経障害治療薬の世界市場力学

  • 視神経障害治療市場のインパクト分析(2019-2029年)
    • 市場促進要因
      • 緑内障の発症率の増加
      • 増え続ける高齢化社会
    • 市場の課題
      • 視神経疾患治療に伴う高額な費用
    • 市場機会
      • 医薬品・バイオテクノロジー産業の拡大
      • ヘルスケア支出の増加

第4章 視神経障害治療薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ(2019-2029年)
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価:COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 視神経障害治療の世界市場:治療タイプ別

  • マーケットスナップショット
  • 視神経障害治療の世界市場:治療タイプ別、実績 - ポテンシャル分析
  • 視神経障害治療の世界市場治療タイプ別推定・予測2019-2029
  • 視神経障害治療市場、サブセグメント別分析
    • 薬物療法
    • 手術の様子

第7章 視神経障害治療薬の世界市場:適応症別

  • マーケットスナップショット
  • 視神経障害治療の世界市場:適応症別、業績別- ポテンシャル分析
  • 視神経障害治療薬の世界市場、適応症別推定・予測2019-2029
  • 視神経障害治療市場、サブセグメント別分析
    • 視神経炎(Optic Neuritis
    • 緑内障
    • 先天性視神経萎縮症
    • オプティック・ニューロパシー
    • その他

第8章 視神経障害治療薬の世界市場:エンドユーザー別

  • マーケットスナップショット
  • 視神経障害治療薬の世界市場:エンドユーザー別、性能- ポテンシャル分析
  • 視神経障害治療の世界市場エンドユーザー別推定・予測2019-2029
  • 視神経障害治療市場、サブセグメント別分析
    • 病院
    • クリニック
    • 外来手術センター
    • その他

第9章 視神経障害治療薬の世界市場:地域別分析

  • 視神経障害治療市場、地域別マーケットスナップショット
  • 北米
    • 米国
      • 治療タイプ別の推定・予測、2019年~2029年
      • 適応症別の推定・予測、2019年~2029年
      • エンドユーザー別の推定・予測、2019年~2029年
    • カナダ
  • 欧州視神経障害治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の視神経障害治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの視神経障害治療市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Santen Pharmaceuticals Co. Limited
      • 主要な情報
      • 概要
      • 財務(データの入手が可能な場合のみ)
      • 製品概要
      • 最近の動向
    • Allergan Plc.
    • Novartis AG
    • Pfizer, Inc.
    • Bausch Health Companies, Inc.
    • Aerie Pharmaceuticals, Inc.
    • Teva Pharmaceutical Industries Ltd.,
    • Bionure Farma, S.L.
    • Mallinckrodt Pharmaceuticals
    • AdvaCarePharma

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Optic Nerve Disorders Treatment Market, report scope
  • TABLE 2. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
  • TABLE 4. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Optic Nerve Disorders Treatment Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 6. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Optic Nerve Disorders Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Optic Nerve Disorders Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Optic Nerve Disorders Treatment Market, research methodology
  • FIG 2. Global Optic Nerve Disorders Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Optic Nerve Disorders Treatment Market, key trends 2021
  • FIG 5. Global Optic Nerve Disorders Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Optic Nerve Disorders Treatment Market, porters 5 force model
  • FIG 7. Global Optic Nerve Disorders Treatment Market, pest analysis
  • FIG 8. Global Optic Nerve Disorders Treatment Market, value chain analysis
  • FIG 9. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Optic Nerve Disorders Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Optic Nerve Disorders Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Optic Nerve Disorders Treatment Market is valued at approximately USD 3.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Optic Nerve Disorders can be defined as patterns of vision loss that are generally caused by developmental disorders or acquired disorders. Moreover, damage to an optic nerve or its pathways to the brain causes, loss of vision. There are different types of disorders that affect the optic nerve, including Coloboma of optic nerve, Glaucoma, Idiopathic intracranial hypertension, Neuromyelitis optica, Optic nerve atrophy, Optic nerve drusen, Optic nerve pit, Optic neuritis, Septo-optic dysplasia, and Toxic amblyopia (nutritional amblyopia) among others. The increasing incidence of glaucoma and growing number of aging populations are key factors driving the market growth.

The rising number of geriatric individuals is contributing towards the growth of the Global Optic Nerve Disorders Treatment Market. According to the World Bank Group, the world's old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Another important component driving space is growing incidences of glaucoma. For instance - World Glaucoma Association - in 2020, globally around 79.6 million individuals were affected by glaucoma in 2020, and as per projections, this number is likely to increase to 111.8 million individuals in 2040. Also, growing expansion of pharmaceutical and biotechnology industries and rising healthcare spending would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Optic Nerve Disorders Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Optic Nerve Disorders Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to factors such as increase in healthcare spending by the governments of nations in these regions and rise in awareness about optic nerve disorders. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and presence of leading market players in the region.

Major market players included in this report are:

  • Santen Pharmaceutical Co. Limited
  • Allergan Plc.
  • Novartis AG
  • Pfizer, Inc.
  • Bausch Health Companies, Inc.
  • Aerie Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.,
  • Bionure Farma, S.L.
  • Mallinckrodt Pharmaceuticals
  • AdvaCarePharma

Recent Developments in the Market:

  • In August 2020, The FDA approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults. NMOSD is a rare autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord.

Global Optic Nerve Disorders Treatment Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Treatment Type, Indication, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Treatment Type

  • Pharmacological
  • Surgery

By Indication

  • Optic Neuritis
  • Glaucoma
  • Congenital Optic Atrophy
  • Optic Neuropathy
  • Others

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Optic Nerve Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Optic Nerve Disorders Treatment Market, by Treatment Type, 2019-2029 (USD Billion)
    • 1.2.3. Optic Nerve Disorders Treatment Market, by Indication, 2019-2029 (USD Billion)
    • 1.2.4. Optic Nerve Disorders Treatment Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Optic Nerve Disorders Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Optic Nerve Disorders Treatment Market Dynamics

  • 3.1. Optic Nerve Disorders Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of glaucoma
      • 3.1.1.2. Growing number of aging populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost associated with optic nerve disorders treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing expansion of pharmaceutical and biotechnology industries
      • 3.1.3.2. Rising healthcare spending

Chapter 4. Global Optic Nerve Disorders Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Optic Nerve Disorders Treatment Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Optic Nerve Disorders Treatment Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
  • 6.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
    • 6.4.1. Pharmacological Treatment
    • 6.4.2. Surgery

Chapter 7. Global Optic Nerve Disorders Treatment Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Optic Nerve Disorders Treatment Market by Indication, Performance - Potential Analysis
  • 7.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
  • 7.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
    • 7.4.1. Optic Neuritis
    • 7.4.2. Glaucoma
    • 7.4.3. Congenital Optic Atrophy
    • 7.4.4. Optic Neuropathy
    • 7.4.5. Others

Chapter 8. Global Optic Nerve Disorders Treatment Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Optic Nerve Disorders Treatment Market by End-User, Performance - Potential Analysis
  • 8.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 8.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Clinics
    • 8.4.3. Ambulatory Surgery Centers
    • 8.4.4. Others

Chapter 9. Global Optic Nerve Disorders Treatment Market, Regional Analysis

  • 9.1. Optic Nerve Disorders Treatment Market, Regional Market Snapshot
  • 9.2. North America Optic Nerve Disorders Treatment Market
    • 9.2.1. U.S. Optic Nerve Disorders Treatment Market
      • 9.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Optic Nerve Disorders Treatment Market
  • 9.3. Europe Optic Nerve Disorders Treatment Market Snapshot
    • 9.3.1. U.K. Optic Nerve Disorders Treatment Market
    • 9.3.2. Germany Optic Nerve Disorders Treatment Market
    • 9.3.3. France Optic Nerve Disorders Treatment Market
    • 9.3.4. Spain Optic Nerve Disorders Treatment Market
    • 9.3.5. Italy Optic Nerve Disorders Treatment Market
    • 9.3.6. Rest of Europe Optic Nerve Disorders Treatment Market
  • 9.4. Asia-Pacific Optic Nerve Disorders Treatment Market Snapshot
    • 9.4.1. China Optic Nerve Disorders Treatment Market
    • 9.4.2. India Optic Nerve Disorders Treatment Market
    • 9.4.3. Japan Optic Nerve Disorders Treatment Market
    • 9.4.4. Australia Optic Nerve Disorders Treatment Market
    • 9.4.5. South Korea Optic Nerve Disorders Treatment Market
    • 9.4.6. Rest of Asia Pacific Optic Nerve Disorders Treatment Market
  • 9.5. Latin America Optic Nerve Disorders Treatment Market Snapshot
    • 9.5.1. Brazil Optic Nerve Disorders Treatment Market
    • 9.5.2. Mexico Optic Nerve Disorders Treatment Market
    • 9.5.3. Rest of Latin America Optic Nerve Disorders Treatment Market
  • 9.6. Rest of The World Optic Nerve Disorders Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Santen Pharmaceuticals Co. Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Allergan Plc.
    • 10.2.3. Novartis AG
    • 10.2.4. Pfizer, Inc.
    • 10.2.5. Bausch Health Companies, Inc.
    • 10.2.6. Aerie Pharmaceuticals, Inc.
    • 10.2.7. Teva Pharmaceutical Industries Ltd.,
    • 10.2.8. Bionure Farma, S.L.
    • 10.2.9. Mallinckrodt Pharmaceuticals
    • 10.2.10. AdvaCarePharma

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption